Kuros Biosciences AG (ETR:YTSN)

Kuros Biosciences AG Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 25, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,041	859	138	54	61	61
Market Cap Growth	387.74%	523.03%	153.55%	-10.72%	-0.52%	20.93%
Enterprise Value	1,023	846	123	35	37	50
PS Ratio	9.41	10.66	3.82	2.99	4.57	16.40
PB Ratio	12.68	13.71	2.26	0.78	0.82	0.78
P/TBV Ratio	27.90	33.12	8.15	2.67	3.01	2.45
P/FCF Ratio	-	393.96	-	-	-	-
P/OCF Ratio	1185.46	256.57	-	-	-	-
EV/Sales Ratio	9.23	10.50	3.41	1.90	2.77	13.27
EV/EBITDA Ratio	147.07	385.86	-	-	-	-
EV/EBIT Ratio	247.51	7414.24	-	-	-	-
EV/FCF Ratio	-1417.52	387.93	-	-	-	-
Debt / Equity Ratio	0.02	0.03	0.04	0.03	0.03	0.03
Debt / EBITDA Ratio	0.28	0.66	-	-	-	-
Debt / FCF Ratio	-	0.88	-	-	-	-
Asset Turnover	1.10	0.97	0.44	0.21	0.15	0.04
Inventory Turnover	1.14	1.18	1.27	1.47	2.33	1.96
Quick Ratio	1.68	1.64	2.22	2.20	2.72	7.69
Current Ratio	2.25	2.14	2.77	2.49	2.91	8.76
Return on Equity (ROE)	-8.62%	-6.44%	-16.18%	-20.02%	-9.33%	-14.18%
Return on Assets (ROA)	2.57%	0.09%	-4.12%	-7.06%	-5.90%	-8.09%
Return on Capital (ROIC)	3.43%	0.11%	-4.90%	-8.21%	-6.59%	-8.81%
Return on Capital Employed (ROCE)	4.60%	0.20%	-	-	-	-
Earnings Yield	-0.62%	-0.53%	-10.70%	-27.17%	-11.95%	-17.39%
FCF Yield	-0.07%	0.25%	-7.14%	-14.41%	-9.13%	-14.04%
Buyback Yield / Dilution	-36.07%	-1.69%	-7.91%	-3.37%	-34.86%	-53.69%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.